TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07228247: A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors

Sponsor: Hutchmed · Phase: PHASE1/PHASE2 · Area: ONCOLOGY · Target Enrollment: 147 pts

Competing Trials Overlap

10 Active Trials

Excess Burn Exposure

$471,240

Rescue Site Savings

+$314,160

Unlock Full NCT07228247 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07228247 Rescue Dossier →